This model also reflects a broader shift in how aesthetic tourism operates. Dr. Soni’s clientele include A-listers from Los Angeles and New York, as well as ultra-high-net-worth families from the UAE, many of whom travel to London specifically for his approach. “They will travel to see the person they trust,” he notes, adding that demand for aesthetic tourism has increased markedly over the past two to three years. In this context, destination matters less than reputation and hotels function as a trusted, neutral platform that gains extra business.
The future of longevity tourism
As the Glowmad mindset matures, the focus is shifting from experience alone to outcomes. Treatments are becoming more transformative (and more expensive) and travelers increasingly want proof that their investment has paid off.
Measurement is likely to become central. Resorts are already experimenting with biometric tracking, blood testing and personalized diagnostics, allowing guests to monitor inflammation markers, antioxidant levels, collagen production, sleep quality and gut health before and after their stay. “If guests can see tangible improvements, they’re far more likely to return,” says Seen Group’s Scott. “It builds loyalty and reinforces the value proposition.”
Food will play a growing role, too. Anti-inflammatory, hormone-balancing menus are becoming standard at high-end wellness destinations, and Scott predicts clearer labeling is next. “I wouldn’t be surprised if menus start calling out hormone-supportive or anti-inflammatory dishes in the same way they currently label vegan or gluten-free options,” she says.
Further ahead, the integration of at-home-style diagnostics into hotel stays may feel less far-fetched than it sounds. “Who’s to say the future Glowmad won’t do a microbiome or stool test in their hotel bathroom?” Scott adds. “There’s a huge opportunity for partnerships here, especially as longevity doctors and biohackers become household names.”